These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6247927)

  • 1. Effect of converting enzyme inhibition on glucocorticoid hypertension in the rat.
    Elijovich F; Krakoff LR
    Am J Physiol; 1980 Jun; 238(6):H844-8. PubMed ID: 6247927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the response to captopril in glucocorticoid hypertension.
    Elijovich F; Krakoff LR
    Clin Exp Hypertens A; 1982; 4(9-10):1795-814. PubMed ID: 6291817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
    Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
    J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.
    Campbell WG; Donohue JA; Duket LH
    Am J Pathol; 1980 Feb; 98(2):457-84. PubMed ID: 6243872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats.
    Levens NR; Peach MJ; Vaughan ED; Weed WC; Carey RM
    Endocrinology; 1981 Feb; 108(2):536-44. PubMed ID: 6256155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin system in hypertension.
    Swales JD
    Pharmacol Ther; 1979; 7(1):173-201. PubMed ID: 230525
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
    Anderson PW; Malarkey WB; Salk J; Kletsky OA; Hsueh WA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):518-22. PubMed ID: 2503532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of renin-angiotensin system in glucocorticoid hypertension in rats.
    Suzuki H; Handa M; Kondo K; Saruta T
    Am J Physiol; 1982 Jul; 243(1):E48-51. PubMed ID: 7046471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New evidence for brain angiotensin and for its role in hypertension.
    Phillips MI
    Fed Proc; 1983 Jul; 42(10):2667-72. PubMed ID: 6305729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of decreased vascular response to angiotensin II in renal vascular hypertension.
    Benedetti RG; Linas SL
    Kidney Int; 1987 Apr; 31(4):906-12. PubMed ID: 3035267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonists, inhibitors and antisera in the evaluation of vascular renin activity. The role of local generation of angiotensin II.
    Swales JD
    Prog Biochem Pharmacol; 1976; 12():98-113. PubMed ID: 798204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension.
    Shoback DM; Williams GH; Moore TJ; Dluhy RG; Podolsky S; Hollenberg NK
    J Clin Invest; 1983 Dec; 72(6):2115-24. PubMed ID: 6358261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats.
    Campbell WB; Schmitz JM; Itskovitz HD
    Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute responses to arterial pressure and plasma renin activity to converting enzyme inhibition (SQ 20,881) in serially studied dogs with neonatally-induced coarctation hypertension.
    Bagby SP
    Hypertension; 1982; 4(1):146-54. PubMed ID: 6174444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of methylprednisolone upon arterial pressure and the renin angiotensin system in the rat.
    Krakoff LR; Selvadurai R; Sutter E
    Am J Physiol; 1975 Feb; 228(2):613-7. PubMed ID: 235222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of extrapulmonary conversion in mediating the systemic pressor activity of angiotensin I.
    Oates HF; Stokes GS
    J Exp Med; 1974 Jul; 140(1):79-86. PubMed ID: 4366060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of renin by an angiotensinogen analog: studies in sodium depletion and renin-dependent hypertension.
    Burton J; Cody RJ; Herd JA; Haber E
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5476-9. PubMed ID: 6159648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium-mediated modulation of aldosterone secretion: impact of converting enzyme inhibition on rat glomerulosa cell response to angiotensin-II.
    Braley LM; Menachery A; Rystedt L; Williams GH
    Endocrinology; 1989 Sep; 125(3):1310-4. PubMed ID: 2547581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.